Mirtazapine for Agitated Behaviors in Dementia

<p>In this episode, Dr. Phelps discusses a study on the efficacy and safety of mirtazapine for treating agitation in patients with dementia. Would prescribing mirtazapine be worth the risk? </p> <p>Faculty: Jim Phelps, M.D. <br /> Host: Jessica Diaz, M.D.</p> <ul> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC181"> <strong>Learn more about our memberships here</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/publication/quick-take-vol-38-2645?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC181"> <strong>Earn 0.5 CMEs: Quick Take Vol. 38</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/study-of-mirtazapine-for-agitated-behaviors-in-dementia-symbad-a-randomised-double-blind-placebo-controlled-trial-2645-5200?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC181"> <strong>Study of Mirtazapine for Agitated Behaviors in Dementia (SYMBAD): A Randomised, Double-Blind, Placebo-Controlled Trial</strong></a></li> </ul> <p> </p> <p> </p>